Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Itai Rusinek"'
Autor:
Alexandre Pellan Cheng, Adam J. Widman, Anushri Arora, Itai Rusinek, William F. Hooper, Rebecca Murray, Daniel Halmos, Theophile Langanay, Giorgio Inghirami, Soren Germer, Melissa Marton, Dina Manaa, Adrienne Helland, Rob Furatero, Jaime McClintock, Lara Winterkorn, Zoe Steinsnyder, Yohyoh Wang, Srinivas Rajagopalan, Asrar I. Alimohamed, Murtaza S. Malbari, Ashish Saxena, Margaret K. Callahan, Dennie T. Frederick, Lavinia Spain, Ariel Jaimovich, Doron Lipson, Samra Turajlic, Michael C. Zody, Nasser K. Altorki, Jedd D. Wolchok, Michael A. Postow, Nicolas Robine, Genevieve Boland, Dan A. Landau
Circulating cell-free DNA (ccfDNA) sequencing for low-burden cancer monitoring is limited by sparsity of circulating tumor DNA (ctDNA), the abundance of genomic material within a plasma sample, and pre-analytical error rates due to library preparatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2354afdf9e5ef98d70483a07b4ead006
https://doi.org/10.1101/2022.11.17.516904
https://doi.org/10.1101/2022.11.17.516904
Autor:
Alexandre P. Cheng, Adam J. Widman, Anushri Arora, Itai Rusinek, William F. Hooper, Rebecca Murray, Daniel Halmos, Theophile Langanay, Giorgio Inghirami, Soren Germer, Melissa Marton, Adrienne Helland, Rob Furatero, Jaime McClintock, Lara Winterkorn, Zoe Steinsnyder, Yohyoh Wang, Srinivas Rajagopalan, Asrar I. Alimohamed, Murtaza S. Malbari, Ashish Saxena, Margaret K. Callahan, Dennie T. Frederick, Lavinia Spain, Ariel Jaimovich, Doron Lipson, Samra Turajlic, Michael C. Zody, Nasser K. Altorki, Jedd D. Wolchok, Michael A. Postow, Nicolas Robine, Genevieve Boland, Dan A. Landau
Publikováno v:
Cancer Research. 83:5709-5709
In many areas of oncology, we lack sensitive tumor-burden monitoring to guide critical decision making. While circulating tumor DNA (ctDNA) promises to enable disease monitoring, this approach is limited by the sparsity of ctDNA in the plasma. To ove
Autor:
Neria Reiss, Avichai Shimoni, Adva Zamir, Gil Harari, Gil Loewenthal, Elinor Debby, Anastasia Paz, Yaniv Amir, Erez Lavi, Almogit Abu-Horowitz, Irit Avivi, Liron Bassali, Nir Skalka, Itai Rusinek, Noam Mamet, Guy Neev, Ido Bachelet, Mor Greenberg
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-9 (2020)
Communications Biology
Communications Biology
Drug discovery is challenged by ineffectiveness of drugs against variable and evolving diseases, and adverse effects due to poor selectivity. We describe a robust platform which potentially addresses these limitations. The platform enables rapid disc
Autor:
Noam Mamet, Avichai Shimoni, Elinor Debby, Almogit Abu-Horowitz, Mor Greenberg, Ido Bachelet, Anastasia Paz, Itai Rusinek, Gil Harari, Yaniv Amir, Nir Skalka, Gil Loewenthal, Guy Neev, Neria Reiss, Adva Zamir, Liron Bassali, Irit Avivi, Erez Lavi
Our current model of drug discovery is challenged by the relative ineffectiveness of drugs against highly variable and rapidly evolving diseases and their relatively high incidence of adverse effects due to poor selectivity. Here we describe a robust
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5d0ae9a77d9b5b1e339fa1a02977a3
https://doi.org/10.1101/629105
https://doi.org/10.1101/629105
Autor:
Noam Mamet, Itai Rusinek, Gil Harari, Zvi Shapira, Yaniv Amir, Erez Lavi, Adva Zamir, Noam Borovsky, Noah Joseph, Maria Motin, Dekel Saban, Ido Bachelet
We describe a technique for the rapid de-novo discovery of target-tailored tumoricidal DNA aptamers inside an Illumina sequencing chip. By sequencing oligonucleotide pools we generate a physical microfluidic map of hundreds of millions of potential a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855e95771d7c255088004fd8096b6bfb
https://doi.org/10.1101/630830
https://doi.org/10.1101/630830